| |
CCSCI
Specialties:
Urologic Oncology

|
Urologic Oncology is a branch of Urology
that involves the diagnosis and treatment of cancers of
the urinary system and male sexual system. The most common
urologic cancers are prostate cancer, bladder cancer, kidney
cancer, and testis cancer. Urologic cancers are diagnosed
in approximately 300,000 Americans each year.
The Urologic Oncologist is trained in
the surgical treatment of patients with urologic cancers.
The Urologic Oncologist is also a team leader and coordinates
care with medical oncologists (who treat cancer with chemotherapy),
radiation oncologists (who treat cancer with radiation therapy),
and support services such as neuropsychology, enterostomal
care, social service, home health care, and complementary
medicine. When appropriate, patients are offered entry into
clinical trials.
The outcome from treatment for cancer
depends upon the type of cancer (where the cancer originated),
the grade (how rapidly the cancer progresses), and the stage
(how far the cancer has progressed). At CCSCI, we have a
treatment option available for every grade and stage of
every type of urologic cancer. Management options can range
from active surveillance (such as in men with low grade
and stage prostate cancer and patients with small kidney
tumors) to a multimodal approach (such as surgery, chemotherapy,
and radiation in patients with advanced bladder cancer).
We have 12 National Cancer Institute supported clinical
trials currently open in bladder, prostate, and kidney cancer.
Our goal in Urologic Oncology at CCSCI
is to provide personalized, comprehensive care for patients
with urologic cancers using state-of-the-art equipment and
treatment options.
Urologic Oncology Services Provided At:
CCSCI Specialties
Medical
Oncology | Radiation
Oncology | Urologic
Oncology | Hematology |
Pain Management
Patient/Family Education | Research
Studies & Clinical Trials
|